Status:
UNKNOWN
Smart Technology for Anorexia Nervosa Recovery
Lead Sponsor:
University of Kansas
Collaborating Sponsors:
Children's Mercy Hospital Kansas City
Purdue University
Conditions:
Anorexia Nervosa
Eligibility:
All Genders
13-21 years
Phase:
NA
Brief Summary
Anorexia nervosa (AN) has the highest mortality rate of any mental illness, with a typical onset in adolescence. Although family-based interventions are efficacious for up to 75 percent of adolescents...
Detailed Description
AN is the third leading cause of chronic illness in adolescents and, if left untreated, can lead to major organ damage, structural and functional brain changes, and early-onset osteopenia and osteopor...
Eligibility Criteria
Inclusion
- Age 13 to 21
- Able to read and speak fluent English
- Access to a smartphone
- Received acute treatment for anorexia nervosa or atypical anorexia nervosa \[residential, inpatient, partial hospitalization (PHP), or intensive outpatient program (IOP)\] within the past three months
- Currently receiving weekly outpatient treatment (or planning to start outpatient treatment) for current anorexia nervosa/atypical anorexia nervosa, or past anorexia nervosa/atypical anorexia nervosa (e.g., anorexia nervosa in partial remission).
Exclusion
- Uncorrected visual impairments that would prevent smartphone use
- Intellectual or developmental disability
- Medical condition that affects appetite or weight (e.g., thyroid disorder, diabetes, cancer, pregnancy)
- Current psychotic disorder or substance use disorder
- BMI-z \< 14 or lab abnormalities indicating medical instability
- Unwillingness for data to be shared with outpatient therapist
Key Trial Info
Start Date :
May 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05190926
Start Date
May 8 2023
End Date
June 30 2024
Last Update
July 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas, Wakarusa Research Facility
Lawrence, Kansas, United States, 66045